文献速递心脑血管急症重症综合管理与镇静镇痛

心脏骤停后目标温度管理33℃与36℃时的血糖异常、血糖变异性与结局

Dysglycemia, Glycemic Variability, and Outcome After Cardiac Arrest and Temperature Management at 33°C and 36°C.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论心脏骤停后目标温度管理试验的事后分析显示,入院时及前36小时血糖更高、血糖变异性更大与6个月神经功能预后差和死亡相关,33℃组高血糖比例高于36℃组。

该研究为多中心TTM试验的事后分析,纳入939例院外心脏骤停(推测心源性)患者,随机接受33℃或36℃目标温度管理。主要结局为6个月神经功能结局(大脑功能分类)。入院时血糖中位数在不同大脑功能分类结局间差异显著(p<0.0001);高血糖和低血糖与神经功能预后差相关(p=0.001和p=0.054)。多因素logistic回归中,血糖中位水平是预后差(大脑功能分类3-5)的独立预测因子,校正模型OR为1.13(p=0.008;95%CI 1.03-1.24)。33℃组高血糖比例高于36℃组。

要点

  • 入院时血糖中位数在不同6个月神经功能结局(大脑功能分类)间差异显著(p<0.0001)。
  • 高血糖与神经功能预后差相关(p=0.001),低血糖与预后差相关(p=0.054)。
  • 校正模型中血糖中位水平是预后差(大脑功能分类3-5)的独立预测因子,OR 1.13(95%CI 1.03-1.24;p=0.008)。
  • 33℃组高血糖比例高于36℃组。
  • 入院时及前36小时血糖更高、血糖变异性更大与神经功能预后差和死亡相关。

适用人群与场景

  • 纳入TTM试验的全部939例院外心脏骤停且推测为心源性病因的患者。
  • 场景为欧洲和澳大利亚36个中心的目标温度管理后监护。

研究设计与关键结果

  • 研究类型:多中心TTM试验的事后分析;样本量939例;36个中心;人群为院外心脏骤停(推测心源性)患者;干预为33℃或36℃目标温度管理。
  • 主要终点:6个月神经功能结局(大脑功能分类);入院时血糖中位数在不同大脑功能分类结局间差异显著(p<0.0001)。
  • 高血糖与神经功能预后差相关(p=0.001),低血糖与神经功能预后差相关(p=0.054)。
  • 多因素logistic回归校正模型中,血糖中位水平是预后差(大脑功能分类3-5)的独立预测因子,OR 1.13(95%CI 1.03-1.24;p=0.008);混合效应模型敏感性分析中亦为预测因子。
  • 33℃组高血糖比例高于36℃组。
  • 结论:入院时及前36小时血糖更高、血糖变异性更大与神经功能预后差和死亡相关。

证据类型、等级与局限

  • 证据类型:多中心随机对照试验(TTM试验)的事后分析。
  • 局限:原文未报告局限性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Dysglycemia and glycemic variability are associated with poor outcomes in critically ill patients. Targeted temperature management alters blood glucose homeostasis. We investigated the association between blood glucose concentrations and glycemic variability and the neurologic outcomes of patients randomized to targeted temperature management at 33°C or 36°C after cardiac arrest.

DESIGN: Post hoc analysis of the multicenter TTM-trial. Primary outcome of this analysis was neurologic outcome after 6 months, referred to as "Cerebral Performance Category."

SETTING: Thirty-six sites in Europe and Australia.

PATIENTS: All 939 patients with out-of-hospital cardiac arrest of presumed cardiac cause that had been included in the TTM-trial.

INTERVENTIONS: Targeted temperature management at 33°C or 36°C.

MEASUREMENTS AND MAIN RESULTS: Nonparametric tests as well as multiple logistic regression and mixed effects logistic regression models were used. Median glucose concentrations on hospital admission differed significantly between Cerebral Performance Category outcomes (p < 0.0001). Hyper- and hypoglycemia were associated with poor neurologic outcome (p = 0.001 and p = 0.054). In the multiple logistic regression models, the median glycemic level was an independent predictor of poor Cerebral Performance Category (Cerebral Performance Category, 3-5) with an odds ratio (OR) of 1.13 in the adjusted model (p = 0.008; 95% CI, 1.03-1.24). It was also a predictor in the mixed model, which served as a sensitivity analysis to adjust for the multiple time points. The proportion of hyperglycemia was higher in the 33°C group compared with the 36°C group.

CONCLUSION: Higher blood glucose levels at admission and during the first 36 hours, and higher glycemic variability, were associated with poor neurologic outcome and death. More patients in the 33°C treatment arm had hyperglycemia.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Borgquist O, Wise MP, Nielsen N, et al. Dysglycemia, Glycemic Variability, and Outcome After Cardiac Arrest and Temperature Management at 33°C and 36°C. Crit Care Med. 2017. PMID: 28708678. doi:10.1097/CCM.0000000000002367

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。